GlobeNewswire: Gemoscan Canada, Inc. Contains the last 10 of 30 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T09:36:02ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2015/01/15/697829/10115783/en/Gemoscan-Canada-Inc-Forms-Corporate-Development-Alliance-With-A-C-Simmonds-and-Sons.html?f=22&fvtc=4&fvtv=19276Gemoscan Canada, Inc. Forms Corporate Development Alliance With A.C. Simmonds and Sons2015-01-15T22:07:00Z<![CDATA[Targets Opportunities in the North American Healthcare Market TORONTO, Jan. 15, 2015 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. (TSX-V:GES) (Munich:1GE) ("Gemoscan" or the "Company"), is pleased to announce that it has formed a strategic alliance with A.C. Simmonds and Sons (the "Alliance"). The Alliance will focus on corporate and business development initiatives focused around Gemoscan's previously stated goals of leveraging its patented intellectual property and proprietary processes to become one of the leading integrated platforms in the rapidly growing multi-billion dollar North American consumer-based healthcare market. The Alliance will help the Company to further expand its position in the health and wellness industry, with a particular focus on natural remedies and treatments.]]>https://www.globenewswire.com/news-release/2015/01/13/697196/10115466/en/Demand-Drives-Gemoscan-Canada-Inc-to-Establish-U-S-Subsidiary-and-Investment-by-Value-Added-Reseller.html?f=22&fvtc=4&fvtv=19276Demand Drives Gemoscan Canada, Inc. to Establish U.S Subsidiary and Investment by Value Added Reseller2015-01-13T22:10:00Z<![CDATA[TORONTO, Jan. 13, 2015 (GLOBE NEWSWIRE) -- Pursuant to its news release of August 07, 2014, Gemoscan Canada, Inc. (TSX-V:GES) (MUN:1GE) ("Gemoscan" or the "Company"), is pleased to announce that it has established a wholly owned subsidiary, Hemocode USA, Inc., ("HUI") through which to sell and market its Hemocode]]>https://www.globenewswire.com/news-release/2014/08/07/657004/10093617/en/The-Hemocode-TM-System-to-be-Available-in-the-United-States-Gemoscan-Canada-Inc-Partners-With-U-S-Lab-to-Provide-Its-Food-Sensitivity-Management-Programs.html?f=22&fvtc=4&fvtv=19276The Hemocode(TM) System to be Available in the United States - Gemoscan Canada, Inc. Partners With U.S. Lab to Provide Its Food Sensitivity Management Programs2014-08-07T15:19:07Z<![CDATA[TORONTO, Aug. 7, 2014 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. (TSX-V:GES) (MUN:1GE) ("Gemoscan" or the "Company"), is pleased to announce that the Hemocode]]>https://www.globenewswire.com/news-release/2014/05/28/640018/10083445/en/Gemoscan-Canada-Inc-Set-to-Acquire-Abira-Healthcare.html?f=22&fvtc=4&fvtv=19276Gemoscan Canada, Inc. Set to Acquire Abira Healthcare2014-05-28T13:53:28Z<![CDATA[TORONTO, May 28, 2014 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") – (TSX-V:GES) (MUN:1GE) is pleased to announce that it has entered into a letter of intent dated May 26, 2014 to acquire all of the issued and outstanding common shares (the "Target Shares") of 2275518 Ontario Inc. operating as Abira Healthcare ("Abira"). The purchase price of the Target Shares will be determined by using a multiple of five times Abira's net cash flow as determined by the TSX Venture Exchange (the "Exchange") for the twelve months ended May 31, 2014. The purchase price shall be entirely paid through the issuance of Gemoscan shares.]]>https://www.globenewswire.com/news-release/2014/05/08/634745/10080847/en/Gemoscan-Canada-Inc-Announces-the-Proposed-Acquisition-of-the-Operations-of-7-Novo-Healthnet-Clinics.html?f=22&fvtc=4&fvtv=19276Gemoscan Canada, Inc. Announces the Proposed Acquisition of the Operations of 7 Novo Healthnet Clinics2014-05-08T20:05:00Z<![CDATA[TORONTO, May 8, 2014 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") – (TSX-V:GES) (MUN:1GE) wishes to announce that it has entered into a letter of intent to undertake a two stage transaction resulting in the Corporation acquiring from Novo Healthnet ("Novo") a 100% interest in 7 paramedical clinics currently owned by Novo ("Novo Businesses") in Southern and Southwestern Ontario (the "Acquisition").]]>https://www.globenewswire.com/news-release/2014/02/28/614222/10070558/en/Gemoscan-Announces-Substantially-Improved-Financial-Results-for-Q3-2014.html?f=22&fvtc=4&fvtv=19276Gemoscan Announces Substantially Improved Financial Results for Q3 20142014-02-28T02:07:08Z<![CDATA[TORONTO, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. (TSX-V:GES) (MUN:1GE) ("Gemoscan" or the "Company"), a leading owner and marketer of food sensitivity and dietary management solutions, today reported operational and financial results for the third quarter and 9 months ended December 31, 2013. In this press release, all dollar amounts are expressed in Canadian currency and results are reported in accordance with International Financial Reporting Standards (IFRS).]]>https://www.globenewswire.com/news-release/2013/12/13/596866/10061490/en/Gemoscan-Canada-Inc-Acquires-Operations-of-The-Physiomed-Yorkdale-Clinic.html?f=22&fvtc=4&fvtv=19276Gemoscan Canada, Inc. Acquires Operations of The Physiomed Yorkdale Clinic2013-12-13T22:40:27Z<![CDATA[TORONTO, Dec. 13, 2013 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. ("]]>https://www.globenewswire.com/news-release/2013/11/29/593573/10059883/en/Gemoscan-Announces-Stronger-Financial-Results-for-Q2-2014.html?f=22&fvtc=4&fvtv=19276Gemoscan Announces Stronger Financial Results for Q2 20142013-11-29T19:24:00Z<![CDATA[TORONTO, Nov. 29, 2013 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. (TSX-V:GES) (MUN:1GE) ("Gemoscan" or the "Company"), a leading owner and marketer of food sensitivity and dietary management solutions, today reported operational and financial results for the 6 months and second fiscal quarter ended September 30, 2013. In this press release, all dollar amounts are expressed in Canadian currency and results are reported in accordance with International Financial Reporting Standards (IFRS).]]>https://www.globenewswire.com/news-release/2013/11/04/586489/10056111/en/Gemoscan-Canada-Inc-Announces-Proposed-Acquisition.html?f=22&fvtc=4&fvtv=19276Gemoscan Canada, Inc. Announces Proposed Acquisition2013-11-04T21:07:40Z<![CDATA[TORONTO, Nov. 4, 2013 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") – (TSX-V:GES) (MUN:1GE) wishes to announce that it has entered into a letter of intent to undertake a two stage transaction resulting in the Corporation acquiring a 100% interest in Physiomed Yorkdale Inc. ("PYI") which operates a paramedical clinic in Toronto Ontario (the "Acquisition").]]>https://www.globenewswire.com/news-release/2013/09/19/574585/10049178/en/Gemoscan-Canada-Inc-Announces-Board-and-Senior-Management-Appointments.html?f=22&fvtc=4&fvtv=19276Gemoscan Canada, Inc. Announces Board and Senior Management Appointments2013-09-19T16:35:00Z<![CDATA[TORONTO, Sept. 19, 2013 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. ("Gemoscan" or the "Company") – (TSX-V:GES) (MUN:1GE) is pleased to announce the appointment of Ms. Elisa Swern to the Board of Directors and Dr. Daniel Bringleson, DC as Senior Vice President of Clinic Operations; both effective immediately. Dr. Bringleson will report to President and CEO, Brian Kalish.]]>